Type 1 Diabetes Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been diagnosed with type 1 diabetes at any point in their life, where the diagnosis was made by a specialist doctor.
- People who were diagnosed with diabetes before the age of 15, were not overweight or obese at the time of diagnosis, have had a serious episode of diabetic ketoacidosis (a dangerous build-up of acids in the blood), and whose C-peptide levels (a marker of insulin production) have never exceeded 200 pmol/L.
- People who started insulin treatment after their diabetes diagnosis and have continued using it (not counting pancreas or islet cell transplants), and who have tested positive for certain antibodies related to type 1 diabetes.
- Children and teenagers who were diagnosed with any type of diabetes at age 20 or younger, regardless of how long they have had it.
Who may not be able to join:
- Adults with type 1 diabetes who did not need insulin for at least the first 6 months after their diagnosis (this exclusion does not apply to those diagnosed at age 20 or younger).
- Adults with type 1 diabetes who have had diabetes for more than one year and were able to go one month without insulin without experiencing diabetic ketoacidosis (confirm with trial site).
- Adults with type 1 diabetes whose C-peptide levels (a measure of the body's own insulin production) have been higher than 800 pmol/L at any point.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Zhiguang Zhou, MD, PhD, The Second Xiangya Hospital, Central South University
Phone: +8673185292154
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Change in serum hemoglobin A1c level; Albumin-to-creatinine ratio in urine sample; Arteriosclerotic cardiovascular diseases; Electromyography; PHQ-9; GAD-7; WHO-5; PAID
Can't join this trial?
Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.